XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Nonredeemable Noncontrolling Interests
Total Equity
Balance at beginning of period (in shares) at Dec. 31, 2022     263,082,000          
Balance at beginning of period at Dec. 31, 2022   $ 22,303,506   $ 19,978,095 $ 2,731,380 $ (405,969) $ 236,704 $ 22,540,210
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 279,786 263,107     263,107   16,683 279,790
Other comprehensive income (loss) $ 35,790 27,568       27,568 7,091 34,659
Stock issued under share-based compensation plans (in shares)     1,273,000          
Stock issued under share-based compensation plans   19,282   19,282       19,282
Common stock repurchased - share-based compensation plans (in shares)     (328,000)          
Common stock repurchased - share-based compensation plans   (36,479)   (36,479)       (36,479)
Share-based compensation expense   136,701   136,701       136,701
Issuance of share-based awards in connection with a business combination   2,484   2,484       2,484
Repurchase of common stock (in shares) (4,064,918)   (4,065,000)          
Repurchases of common stock $ (414,000) (414,048)   (414,048)       (414,048)
Distributions to noncontrolling interests             (15,984) (15,984)
Cash dividends declared   (130,635)     (130,635)     (130,635)
Balance at end of period (in shares) at Jun. 30, 2023     259,962,000          
Balance at end of period at Jun. 30, 2023   22,171,486   19,686,035 2,863,852 (378,401) 244,494 22,415,980
Beginning balance at Dec. 31, 2022 0              
Redeemable Noncontrolling Interests                
Net income (loss) (4)              
Other comprehensive income (loss) 1,131              
Redeemable noncontrolling interests measurement period adjustment 556,070              
Distributions to noncontrolling interests (1,271)              
Redeemable noncontrolling interests measurement period adjustment (56,447)              
Ending balance at Jun. 30, 2023 499,479              
Balance at beginning of period (in shares) at Mar. 31, 2023     261,771,000          
Balance at beginning of period at Mar. 31, 2023   22,083,278   19,839,506 2,654,589 (410,817) 243,481 22,326,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 284,206 274,148     274,148   10,062 284,210
Other comprehensive income (loss) $ 34,264 32,416       32,416 717 33,133
Stock issued under share-based compensation plans (in shares)     259,000          
Stock issued under share-based compensation plans   13,179   13,179       13,179
Common stock repurchased - share-based compensation plans (in shares)     (62,000)          
Common stock repurchased - share-based compensation plans   (6,290)   (6,290)       (6,290)
Share-based compensation expense   47,135   47,135       47,135
Repurchase of common stock (in shares) (2,006,016)   (2,006,000)          
Repurchases of common stock $ (207,500) (207,495)   (207,495)       (207,495)
Distributions to noncontrolling interests             (9,766) (9,766)
Cash dividends declared   (64,885)     (64,885)     (64,885)
Balance at end of period (in shares) at Jun. 30, 2023     259,962,000          
Balance at end of period at Jun. 30, 2023   22,171,486   19,686,035 2,863,852 (378,401) 244,494 22,415,980
Beginning balance at Mar. 31, 2023 556,070              
Redeemable Noncontrolling Interests                
Net income (loss) (4)              
Other comprehensive income (loss) 1,131              
Redeemable noncontrolling interests measurement period adjustment (56,447)              
Distributions to noncontrolling interests (1,271)              
Ending balance at Jun. 30, 2023 499,479              
Balance at beginning of period (in shares) at Dec. 31, 2023     260,383,000          
Balance at beginning of period at Dec. 31, 2023 23,279,550 22,999,210   19,800,953 3,457,182 (258,925) 280,340 23,279,550
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 712,337 688,067     688,067   20,436 708,503
Other comprehensive income (loss) $ (163,534) (133,362)       (133,362) (22,618) (155,980)
Stock issued under share-based compensation plans (in shares)     1,277,000          
Stock issued under share-based compensation plans   25,137   25,137       25,137
Common stock repurchased - share-based compensation plans (in shares)     (334,000)          
Common stock repurchased - share-based compensation plans   (44,044)   (44,044)       (44,044)
Share-based compensation expense   83,362   83,362       83,362
Repurchase of common stock (in shares) (6,972,979)   (6,973,000)          
Repurchases of common stock $ (909,200) (909,237)   (909,237)       (909,237)
Distributions to noncontrolling interests   0         (10,881) (10,881)
Contributions from noncontrolling interests 2,027 0         89 89
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest   0         358,872 358,872
Purchase of capped calls related to issuance of convertible notes, net of taxes   (194,677)   (194,677)       (194,677)
Cash dividends declared   (127,042)     (127,042)     (127,042)
Balance at end of period (in shares) at Jun. 30, 2024     254,353,000          
Balance at end of period at Jun. 30, 2024 23,013,652 22,387,414   18,761,494 4,018,207 (392,287) 626,238 23,013,652
Beginning balance at Dec. 31, 2023 507,965              
Redeemable Noncontrolling Interests                
Net income (loss) 3,834              
Other comprehensive income (loss) (7,554)              
Reclassification of redeemable noncontrolling interest to nonredeemable noncontrolling interest (358,872)              
Ending balance at Jun. 30, 2024 147,400              
Balance at beginning of period (in shares) at Mar. 31, 2024     255,131,000          
Balance at beginning of period at Mar. 31, 2024   22,215,831   18,806,396 3,706,873 (297,438) 627,245 22,843,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 389,275 374,760     374,760   12,743 387,503
Other comprehensive income (loss) $ (101,934) (94,849)       (94,849) (7,617) (102,466)
Stock issued under share-based compensation plans (in shares)     145,000          
Stock issued under share-based compensation plans   14,106   14,106       14,106
Common stock repurchased - share-based compensation plans (in shares)     (12,000)          
Common stock repurchased - share-based compensation plans   (1,381)   (1,381)       (1,381)
Share-based compensation expense   43,245   43,245       43,245
Repurchase of common stock (in shares) (910,980)   (911,000)          
Repurchases of common stock $ (100,900) (100,872)   (100,872)       (100,872)
Distributions to noncontrolling interests             (6,133) (6,133)
Contributions from noncontrolling interests 2,027              
Cash dividends declared   (63,426)     (63,426)     (63,426)
Balance at end of period (in shares) at Jun. 30, 2024     254,353,000          
Balance at end of period at Jun. 30, 2024 23,013,652 $ 22,387,414   $ 18,761,494 $ 4,018,207 $ (392,287) $ 626,238 $ 23,013,652
Beginning balance at Mar. 31, 2024 143,069              
Redeemable Noncontrolling Interests                
Net income (loss) 1,772              
Other comprehensive income (loss) 532              
Ending balance at Jun. 30, 2024 $ 147,400